Second-line chemotherapy and its evaluation in small cell lung cancer
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 25 (4), 199-206
- https://doi.org/10.1053/ctrv.1999.0125
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung CancerOncology, 1996
- Activity of docetaxel (Taxotere) in small cell lung cancerEuropean Journal Of Cancer, 1994
- Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patientsEuropean Journal Of Cancer, 1993
- Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative groupEuropean Journal Of Cancer, 1993
- Response of Small-Cell Lung Cancer Xenografts to Chemotherapy: Multidrug Resistance and Direct Clinical CorrelatesJNCI Journal of the National Cancer Institute, 1993
- Predictors of survival following relapse or progression of small cell lung cancer. Southwest oncology group study 8605 report and analysis of recurrent disease data baseCancer, 1993
- Second-line chemotherapy in small cell lung cancerCancer Treatment Reviews, 1990
- Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group StudyCancer, 1990
- Reinduction chemotherapy in small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1987